Skip to main content
. 1984 Spring;5(3):69–88.

Table 8. Medicare ESRD program incidence, by diagnosis and age: 1980.

Diagnosis 0-14 years 15-24 years 25-34 years 35-44 years 45-54 years 55-64 years 65-74 years 75 years and over
Number of persons 137 472 1060 1113 1530 2126 2065 807
Percent distribution
All causes 100 100 100 100 100 100 100 100
Glomerulonephritis 37.2 40.0 30.7 24.0 17.6 15.2 14.6 12.6
Primary hypertensive disease 0.0 5.9 11.9 20.0 24.4 25.0 29.1 36.7
Diabetic nephropathy 0.7 5.5 30.8 28.1 24.3 25.9 17.4 10.4
Polycystic kidney disease 6.6 1.1 2.3 7.5 10.7 7.4 4.5 2.0
Collagen vascular disease 2.2 4.7 2.5 2.1 1.4 0.6 0.8 0.4
Interstitial nephritis, hereditary 2.9 4.4 2.2 0.9 0.5 0.7 0.3 0.4
Interstitial nephritis, other 4.4 8.1 5.1 4.1 5.6 6.6 7.1 9.3
Analgesic abuse nephropathy 0.0 0.2 0.1 1.3 1.2 1.7 1.3 0.2
Obstructive uropathy, acquired 0.7 1.1 0.7 0.4 1.4 2.4 4.2 5.8
Obstructive uropathy, congenital 18.2 9.1 2.0 0.6 0.1 0.1 0.1 0.0
Amyloidosis 0.0 0.0 0.0 0.4 0.7 0.7 0.8 0.5
Multiple myeloma 0.0 0.0 0.0 0.4 0.6 1.3 1.9 2.1
Gouty nephropathy 0.7 0.2 0.2 0.2 0.7 0.5 0.6 0.7
Other, unspecified 20.4 13.1 6.4 3.6 3.5 4.3 12.7 4.2
Etiology unknown 5.8 6.6 5.2 6.5 7.2 7.7 4.4 14.6